GC3114BNCT07883928
Clinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or Older
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Start date changed from estimate of Oct 2026 to Oct 12, 2026
- Site details revised
- Study title shortened, about 2 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Evaluation of the immunogenicity of GC3114B
Timeframe: Day 28 following IP vaccination
Secondary (2)
Evaluation of the safety of GC3114B
Evaluation the safety of GC3114B
Arms and interventions
GC3114BExperimental
inactivated, split influenza vaccine
EflueldaActive comparator
Inactivated split influenza vaccine
Biologicals: vaccination of GC3114B, Vaccination of Efluelda
Sites
1 site in 1 country
- Korea University Guro HospitalSeoul, Seoul, South Korea